文献速递免疫规划卫生政策与健康促进

喷雾干燥的人与黑猩猩腺病毒载体疫苗热稳定且体内免疫原性良好

Spray dried human and chimpanzee adenoviral-vectored vaccines are thermally stable and immunogenic in vivo.
PubMed 文献 · Vaccine · 2017-04-21

研究将人腺病毒(AdHu5)和黑猩猩腺病毒(AdCh68)载体结核疫苗在甘露醇和右旋糖酐基质中喷雾干燥,粉末具长期热稳定性所需理化性质,复溶后体外转染细胞伴与喷雾干燥相关的较小感染性损失。体内接种后两种疫苗免疫原性与新鲜冻存液体疫苗相当,无冷链室温低湿储存30和90天后仍保留体内免疫原性,而液体疫苗几乎完全失去免疫激活能力。

要点

  • 喷雾干燥AdHu5和AdCh68载体结核疫苗粉末具备长期热稳定性所需理化特性。
  • 复溶后体外转染细胞,感染性损失相对较小且与喷雾干燥过程相关。
  • 无冷链储存30和90天后粉末疫苗保留体内免疫原性,液体疫苗几乎完全丧失。

核心结论

  • 喷雾干燥的人与黑猩猩腺病毒载体疫苗热稳定且体内免疫原性良好,支持进一步开发该喷雾干燥技术用于制备热稳定的腺病毒载体及其他病毒载体疫苗。

研究设计与样本

  • 将人腺病毒(AdHu5)和黑猩猩腺病毒(AdCh68)载体结核疫苗在甘露醇和右旋糖酐基质中喷雾干燥,并评价粉末理化性质、复溶后体外转染与感染性、以及体内接种后的免疫原性。
  • 比较喷雾干燥疫苗与常规新鲜、冻存液体疫苗样品的体内免疫原性,并评估无冷链室温低湿储存30和90天后的体内免疫原性。

主要发现

  • 喷雾干燥粉末显示长期热稳定性和疫苗接种所需的形态学和化学性质。
  • 复溶后有效转染细胞,体外感染性损失相对较小且与喷雾干燥过程相关。
  • 体内接种后AdHu5和AdCh68载体疫苗免疫原性与常规新鲜、冻存液体疫苗样品相当。
  • 无冷链室温低湿储存30和90天后疫苗保留体内免疫原性,而相同条件下储存的液体疫苗样品几乎完全失去免疫激活能力。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cold chain-free vaccine technologies are needed to ensure effective vaccine delivery and coverage, particularly in resource-poor countries. However, the immunogenicity and thermostability of spray dried live viral vector-based vaccines such as recombinant adenoviral-vectored vaccines remain to be investigated. To address this issue, we have spray dried human adenoviral (AdHu5)- and chimpanzee adenoviral (AdCh68)-vectored tuberculosis vaccines in a mannitol and dextran matrix. Spray dried powders containing these two vaccines display the morphologic and chemical properties desired for long-term thermostability and vaccination. Upon reconstitution, they effectively transfected the cells in vitro with relatively small losses in viral infectivity related to the spray drying process. Following in vivo vaccination, AdHu5- and AdCh68-vectored vaccines were as immunogenic as the conventional fresh, cryopreserved liquid vaccine samples. Of importance, even after cold chain-free storage, at ambient temperatures and relatively low humidity for 30 and 90days, the vaccines retained their in vivo immunogenicity, while the liquid vaccine samples stored under the same conditions lost their immune-activating capability almost entirely. Our results support further development of our spray drying technologies for generating thermally stable adenoviral-vectored and other viral-vectored vaccines.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Afkhami S, LeClair DA, Haddadi S, et al. Spray dried human and chimpanzee adenoviral-vectored vaccines are thermally stable and immunogenic in vivo. Vaccine. 2017. PMID: 28438408. doi:10.1016/j.vaccine.2017.04.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。